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Summary and Implications 
 Polyvalent hyperimmune plasma (HP) with high-titers 
of virus neutralizing (VN) antibody to porcine reproductive 
and respiratory syndrome virus (PRRSV) strains was 
produced in gilts and used to passively immunize 3 week 
old piglets. The piglets were subsequently challenged with 
live virus. Results showed delay of viremia, decrease in live 
virus titers, decrease in gross lung lesions, or delay in 
transmission to naïve, non-immunized sentinel pigs.   
 
Introduction 
 Passive immunization of pregnant sows with high-titer 
VN antibody against PRRSV, prior to live virus challenge, 
has been shown to increase piglet viability at farrowing. The 
goal of our research was to produce polyvalent 
hyperimmune plasma (HP) with high-titers of VN antibody 
to PRRSV strains, and to evaluate protection provided by 
passive immunization of 3-week old piglets.  
 
Materials and Methods 
 Hyperimmune plasma with neutralizing antibodies (α-
PRRSV) was induced by injection of naïve gilts with 3 live 
strains of PRRSV: HLV013, HLV093, and HLV096. 
Normal swine plasma (NSP) was harvested from PRRSV 
negative gilts.  Plasma was harvested at necropsy.  
  
Study 1:  16 pigs were randomized into the following 
groups: 1—NSP challenged, 2—α-PRRSV challenged, 3—
α-PRRSV non-challenged, 4—naïve sentinels exposed to 
NSP pigs, 5—naïve sentinels exposed to α-PRRSV pigs.  
Pigs were intraperitoneally (IP) administered 0.6 ml/kg of 
bodyweight (bw) of the appropriate plasma at day 0. HP had 
an FFN titer of 1:1024 against the challenge strain.  At 1 day 
post immunization (dpi), pigs were challenged intranasally 
(IN) with 2 ml of a HLV013.  At 3 days post challenge 
(dpc), naïve sentinel pigs were moved into the appropriate 
room for 0 days post exposure (dpe).  Pigs were bled at 0, 3, 
7, 10, 14, and 21 dpe.    
Study 2:  12 pigs were randomized into the following 
groups: 1—NSP challenged, 2—α-PRRSV challenged, 3—
naïve sentinels exposed to NSP pigs, 4—naïve sentinels 
exposed to α-PRRSV pigs.  Pigs were subcutaneously (SC) 
administered 2ml/kg bw of the HP. Challenge virus was 
HLV013.   
 
Study 3:  The same experimental design as challenge study 
2 was repeated with challenge virus HLV096.  HP had an 
FFN titer of 1:512 against the challenge strain. 
 
 Sera from all three studies was submitted to Iowa State 
University Veterinary Diagnostic Laboratory for IDEXX 
ELISA, and to South Dakota State University Animal 
Disease Research and Diagnostic Laboratory for fluorescent 
focus neutralization (FFN) assay.  Geometric mean of 
inverse FFN titers was calculated for each treatment group. 
Live virus titration and gross lung lesions were scored as 
previously described. 
 
Results and Discussion 
 Pigs immunized with 0.6 ml/kg IP of HP had positive 
VN titers (Figure 1A).  The α-PRRSV challenged pigs had a 
2 log decrease in viremia at 3 and 6 dpc as compared to the 
NSP pigs (Figure 1B).  Sentinel pigs exposed to α-PRRSV 
pigs also had a decrease in viremia as compared to the 
sentinel pigs exposed to NSP pigs.  When immunization 
volume was increased and administered subcutaneously, 
FFN titers increased and there was a delay in viremia and 
decrease in lung lesion scores (Figure 2) in the α-PRRSV 
pigs. In challenge study 3, α-PRRSV challenged pigs did 
not become viremic until 14 dpc, and sentinels exposed to 
these pigs never became viremic (Figure 3B).  Lung scores 
were numerically different among groups. 
 Partial protection was provided against homologous 
PRRSV strains by delaying or decreasing viremia, 
decreasing gross lung lesion scores, and delaying or 
decreasing transmission to naïve sentinel pigs.  Future 
studies will test heterologous challenge strains.   
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Figure 1. Challenge study 1 results. Mean of inverse FFN titers is shown for each group.  Gross lung lesions means 
were calculated for each group.   
 
 
 
 
 
 
 
 
 
Iowa State University Animal Industry Report 2009 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
38.05
2.00
38.05
2.00
22.63
2.00
19.03
2.00
1.00
10.00
100.00
In
ve
rs
e 
FF
N
 ti
te
rs
 (2
-f
ol
d 
di
lu
tio
ns
)
1 4 7 11
Days post immunization
Challenge study 2: Mean inverse FFN titers by treatment group
α-PRRSV challenge
NSP challenge
 
 
 
 
7
26
29
10
0
10
20
30
40
50
60
70
M
ea
n 
gr
os
s 
lu
ng
 le
si
on
 s
Treatment group
Challenge study 2: Mean gross lung lesion scores
α-PRRSV challenge
NSP challenge
Sentinels exposed
 to α-PRRSV
Sentinels exposed
 to NSP
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Challenge study 2 results. Mean of inverse FFN titers is shown for each groupGross lung lesions means were 
calculated for each group.  
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Figure 3. Challenge study 3 results. Mean of inverse FFN titers is shown for each group. Gross lung lesions means 
were calculated for each group.   
